| Year |
Citation |
Score |
| 2020 |
Mardis ER, Ribas A, Hait WN, Jaffee EM, Foti M, Abate-Shen C, Albini A, Bernards R, Cruz-Correa MR, Flaherty KT, Greenberg PD, June CH, Knudsen KE, Liu ET, Mills GB, et al. AACR calls on congress to take immediate action against COVID-19 and protect patients with cancer during the pandemic Cancer Discovery. 10: 771-774. PMID 32295764 DOI: 10.1158/2159-8290.Cd-20-0449 |
0.304 |
|
| 2020 |
Yu CI, Wu T, Kim KI, Menghi F, Oliveira V, Marches F, Liu ET, Banchereau J, Palucka K. Abstract P1-03-05: Patient-derived xenografts in humanized mice classify metastatic potential of primary triple negative breast cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P1-03-05 |
0.341 |
|
| 2018 |
Inselmann S, Wang Y, Saussele S, Fritz L, Schütz C, Huber M, Liebler S, Ernst T, Cai D, Botschek S, Brendel CA, Calogero R, Pavlinic D, Benes V, Liu ET, et al. Development, function and clinical significance of plasmacytoid dendritic cells in chronic myeloid leukemia. Cancer Research. PMID 30166420 DOI: 10.1158/0008-5472.Can-18-1477 |
0.312 |
|
| 2018 |
Cho SY, Sung CO, Chae J, Lee J, Na D, Kang W, Kang J, Min S, Lee A, Kwak E, Kim J, Choi B, Kim H, Chuang JH, Pak HK, ... ... Liu ET, et al. Alterations in the Rho pathway contribute to Epstein-Barr virus-induced lymphomagenesis in immunosuppressed environments. Blood. PMID 29475961 DOI: 10.1182/Blood-2017-07-797209 |
0.339 |
|
| 2018 |
Liu E, Menghi F, Barthel F, Yadav V, Tang M, Ji B, Carter G, Jonkers J, Verhaak R. Abstract GS1-05: Tandem duplicator phenotypes define 50% of triple negative breast cancers Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Gs1-05 |
0.409 |
|
| 2018 |
Yao L, Cheng M, Aryee K, Kumar P, Walsh N, Greiner D, Shultz L, Liu ET, Brehm M, Keck JG. Abstract 5676: Patient-derived tumor xenografts in humanized NSG-SGM3 mice: An improved immuno-oncology platform Cancer Research. 78: 5676-5676. DOI: 10.1158/1538-7445.Am2018-5676 |
0.313 |
|
| 2017 |
Kim H, Kumar P, Menghi F, Cerveira E, Romanovitch M, Ananda G, George J, Chen H, Mockus S, Zhang C, Yang Y, Keck J, Karuturi RKM, Bult C, Lee C, ... Liu E, et al. Abstract 2909: High-precision quantification of clonal evolution during comparative treatments of triple negative breast cancer Cancer Research. 77: 2909-2909. DOI: 10.1158/1538-7445.Am2017-2909 |
0.332 |
|
| 2016 |
Menghi F, Liu ET. Reply to Watkins et al.: Whole-genome sequencing-based identification of diverse tandem duplicator phenotypes in human cancers. Proceedings of the National Academy of Sciences of the United States of America. PMID 27543335 DOI: 10.1073/Pnas.1610624113 |
0.365 |
|
| 2016 |
Menghi F, Inaki K, Woo X, Kumar PA, Grzeda KR, Malhotra A, Yadav V, Kim H, Marquez EJ, Ucar D, Shreckengast PT, Wagner JP, MacIntyre G, Murthy Karuturi KR, Scully R, ... ... Liu ET, et al. The tandem duplicator phenotype as a distinct genomic configuration in cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 27071093 DOI: 10.1073/Pnas.1520010113 |
0.357 |
|
| 2016 |
Liu ET, Bult C, Chuang J, Kumar P, Cheng M, Karuturi RKM, Philip V, Keck J, Palucka K, Shultz L. Abstract IA29: Mice host selection for patient-derived xenograft (PDX) model development and other critical factors for success Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-Ia29 |
0.357 |
|
| 2016 |
Liu ET, Keck J, Airhart S, Shultz L, Lee C, Bult C. Abstract IA13: The Patient-Derived Xenograft Program at The Jackson Laboratory Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-Ia13 |
0.359 |
|
| 2016 |
Kim H, Kumar P, Menghi F, George J, Ananda G, Mockus S, Zhang C, Larson N, Chen HC, Yang Y, Keck J, Karuturi RK, Lee C, Bult C, Liu E, et al. Abstract 2411: Evolution during propagation and treatment of patient-derived triple negative breast cancer xenografts Cancer Research. 76: 2411-2411. DOI: 10.1158/1538-7445.Am2016-2411 |
0.376 |
|
| 2015 |
Pan CX, Zhang H, Tepper CG, Lin TY, Davis RR, Keck J, Ghosh PM, Gill P, Airhart S, Bult C, Gandara DR, Liu E, de Vere White RW. Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy. Plos One. 10: e0134346. PMID 26270481 DOI: 10.1371/Journal.Pone.0134346 |
0.352 |
|
| 2015 |
Gandara DR, Mack PC, Bult C, Li T, Lara PN, Riess JW, Astrow SH, Gandour-Edwards R, Cooke DT, Yoneda KY, Moore EH, Pan CX, Burich RA, David EA, Keck JG, ... ... Liu ET, et al. Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform. Clinical Lung Cancer. 16: 165-72. PMID 25838158 DOI: 10.1016/J.Cllc.2015.03.001 |
0.408 |
|
| 2015 |
Bertrand D, Chng KR, Sherbaf FG, Kiesel A, Chia BK, Sia YY, Huang SK, Hoon DS, Liu ET, Hillmer A, Nagarajan N. Patient-specific driver gene prediction and risk assessment through integrated network analysis of cancer omics profiles. Nucleic Acids Research. 43: e44. PMID 25572314 DOI: 10.1093/nar/gku1393 |
0.303 |
|
| 2015 |
Pan C, Zhang H, Lin T, Tepper C, Keck J, Ghosh P, Airhart SD, Bult CJ, Gandara DR, Evans CP, Liu ET, deVere White R. Patient-derived xenograft platform to guide precision medicine in bladder cancer. Journal of Clinical Oncology. 33: 315-315. DOI: 10.1200/Jco.2015.33.7_Suppl.315 |
0.355 |
|
| 2015 |
Pan AW, Zhang H, Lin T, Li Y, Li T, Keck J, Tepper C, Airhart SD, Liu ET, Pan C, de Vere White R, Lam KS. Patient-derived bladder cancer xenografts as a platform for drug development in bladder cancer. Journal of Clinical Oncology. 33: e15528-e15528. DOI: 10.1200/Jco.2015.33.15_Suppl.E15528 |
0.35 |
|
| 2015 |
Pan C, Zhang H, Lin T, Tepper C, Keck J, Ghosh P, Airhart SD, Carvajal-Carmona L, Bult CJ, Gandara DR, Liu ET, de Vere White R. Development and characterization of patient-derived xenografts to guide precision medicine in bladder cancer. Journal of Clinical Oncology. 33: e15522-e15522. DOI: 10.1200/Jco.2015.33.15_Suppl.E15522 |
0.331 |
|
| 2015 |
Curry E, Cheraghchi-Bashi-Astaneh A, Chen M, Cunnea P, Camila DS, Maginn E, Dai Y, Liu E, Wasan H, Mills GB, Bowtell D, Gabra H, Stronach EA. Abstract A47: DNA-PKcs is amplified in high-grade serous ovarian cancer (HGSC), correlates with poor outcome and drives resistance to platinum therapy via the AKT signaling pathway Molecular Cancer Therapeutics. 14. DOI: 10.1158/1538-8514.Pi3K14-A47 |
0.332 |
|
| 2015 |
Graber JH, Keck JG, Airhart SD, Bult CJ, Liu ET. Abstract P6-06-02: Molecular characterization of a patient-derived xenograft (PDX) resource for triple negative breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P6-06-02 |
0.427 |
|
| 2014 |
Grzeda KR, Royer-Bertrand B, Inaki K, Kim H, Hillmer AM, Liu ET, Chuang JH. Functional chromatin features are associated with structural mutations in cancer. Bmc Genomics. 15: 1013. PMID 25417144 DOI: 10.1186/1471-2164-15-1013 |
0.357 |
|
| 2014 |
Inaki K, Menghi F, Woo XY, Wagner JP, Jacques PÉ, Lee YF, Shreckengast PT, Soon WW, Malhotra A, Teo AS, Hillmer AM, Khng AJ, Ruan X, Ong SH, Bertrand D, ... ... Liu ET, et al. Systems consequences of amplicon formation in human breast cancer. Genome Research. 24: 1559-71. PMID 25186909 DOI: 10.1101/Gr.164871.113 |
0.316 |
|
| 2014 |
Utami KH, Hillmer AM, Aksoy I, Chew EG, Teo AS, Zhang Z, Lee CW, Chen PJ, Seng CC, Ariyaratne PN, Rouam SL, Soo LS, Yousoof S, Prokudin I, Peters G, ... ... Liu ET, et al. Detection of chromosomal breakpoints in patients with developmental delay and speech disorders. Plos One. 9: e90852. PMID 24603971 DOI: 10.1371/Journal.Pone.0090852 |
0.349 |
|
| 2014 |
Bult CJ, Airhart SD, Chuang J, Gandour-Edwards R, George J, Graber J, Karuturi RKM, Keck J, Kim H, Lara P, Li T, Mack PC, Shultz L, Tepper C, Burich R, ... ... Liu ET, et al. The JAX patient-derived xenograft program: A unique resource to advance genome-guided cancer medicine and therapeutic agent testing. Journal of Clinical Oncology. 32: e22151-e22151. DOI: 10.1200/Jco.2014.32.15_Suppl.E22151 |
0.306 |
|
| 2014 |
Mack PC, Bult CJ, Goodwin N, Airhart SD, Burich R, Tepper C, Lara P, Liu ET, Gandara DR. Molecular characterization of an extensive lung cancer patient-derived xenograft (PDX) resource. Journal of Clinical Oncology. 32: 8025-8025. DOI: 10.1200/Jco.2014.32.15_Suppl.8025 |
0.303 |
|
| 2014 |
Pan C, Zhang H, Tepper C, Ghosh P, Kuslak-Meyer S, Airhart SD, Gandara DR, Liu ET, White Rd. A patient-derived xenograft (PDX) platform to optimize omics-driven precision medicine in bladder cancer. Journal of Clinical Oncology. 32: 4536-4536. DOI: 10.1200/Jco.2014.32.15_Suppl.4536 |
0.345 |
|
| 2014 |
Pan C, Zhang H, Tepper C, Ghosh P, Kuslak-Meyer S, Airhart S, Gill P, Gandara D, Liu E, White RdV. Abstract LB-32: Patient-derived xenograft (PDX) paraclinical platform to guide precision medicine in urothelial cancer Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-32 |
0.386 |
|
| 2014 |
Sherbaf FG, Inaki K, Bertrand D, Woo XY, Hoon D, Hillmer A, Liu E. Abstract 3414: Genomic signatures of melanoma maintenance Cancer Research. 74: 3414-3414. DOI: 10.1158/1538-7445.Am2014-3414 |
0.438 |
|
| 2013 |
Madak-Erdogan Z, Charn TH, Jiang Y, Liu ET, Katzenellenbogen JA, Katzenellenbogen BS. Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators. Molecular Systems Biology. 9: 676. PMID 23774759 DOI: 10.1038/Msb.2013.28 |
0.377 |
|
| 2013 |
Liu ET. Grappling with cancer Science. 340: 1493. PMID 23539566 DOI: 10.1126/Science.1237835 |
0.411 |
|
| 2013 |
Sherbaf FG, Heng CLW, Woo XY, Bertrand D, Inaki K, Chong KC, Morton D, Huang S, Hoon D, Liu E. Abstract 2001: Genomic signatures of melanoma progression and maintenance. Cancer Research. 73: 2001-2001. DOI: 10.1158/1538-7445.Am2013-2001 |
0.37 |
|
| 2013 |
Wagner JP, Liu ET. Abstract B137: Oncogenic chromosomal blocks in cancer genomes. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-B137 |
0.412 |
|
| 2012 |
Inaki K, Liu ET. Structural mutations in cancer: mechanistic and functional insights. Trends in Genetics : Tig. 28: 550-9. PMID 22901976 DOI: 10.1016/J.Tig.2012.07.002 |
0.372 |
|
| 2012 |
Menghi F, Woo X, Gong M, Rouam SL, Bertrand D, Lee WH, Wang W, Rama N, Stronach EA, Karuturi K, Gabra H, Agarwal R, Liu ET. Abstract 5107: Unravelling the complexity of individual cancer genomes Cancer Research. 72: 5107-5107. DOI: 10.1158/1538-7445.Am2012-5107 |
0.406 |
|
| 2012 |
Woo XY, Menghi F, Inaki K, Gong M, Hillmer A, Sherbaf F, Liu E. Abstract 4947: Analysis of structural mutations in cancer genomes Cancer Research. 72: 4947-4947. DOI: 10.1158/1538-7445.Am2012-4947 |
0.405 |
|
| 2012 |
Lung HL, Cheung AKL, Chung YM, Liu ET, Chua D, Lung ML. Abstract 3998: The role of serum amyloid A1 (SAA1) in nasopharyngeal carcinoma (NPC) Cancer Research. 72: 3998-3998. DOI: 10.1158/1538-7445.Am2012-3998 |
0.412 |
|
| 2012 |
Hwang IY, Yuan J, Ning G, Tay SW, Yamamoto Y, Menghi F, Liu E, Crum CP, McKeon F, Xian W. Abstract 114: Study of the high-grade ovarian cancer precursors in the oviduct Cancer Research. 72: 114-114. DOI: 10.1158/1538-7445.Am2012-114 |
0.399 |
|
| 2012 |
Sherbaf FG, Lee CW, Woo XY, Bertrand D, Inaki K, Chong K, Morton DL, Huang S, Hoon DS, Liu ET. 585 Genomics of Metastatic Progression in Cutaneous Melanoma European Journal of Cancer. 48. DOI: 10.1016/S0959-8049(12)71242-X |
0.302 |
|
| 2011 |
Kong SL, Li G, Loh SL, Sung WK, Liu ET. Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state. Molecular Systems Biology. 7: 526. PMID 21878914 DOI: 10.1038/Msb.2011.59 |
0.367 |
|
| 2011 |
Zaenker KS, Mihich E, Liu E. Personalized Cancer Medicine 2011: Toward Individualized Cancer Treatments. XV International Fritz Bender Symposium Held on February 21 to 23, 2011 at Matrix, Biopolis, Singapore. Translational Oncology. 4: 199-202. PMID 21804914 DOI: 10.1593/Tlo.11142 |
0.339 |
|
| 2011 |
Soon WW, Miller LD, Black MA, Dalmasso C, Chan XB, Pang B, Ong CW, Salto-Tellez M, Desai KV, Liu ET. Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer. Embo Molecular Medicine. 3: 451-64. PMID 21656687 DOI: 10.1002/Emmm.201100150 |
0.395 |
|
| 2011 |
Lam SH, Lee SG, Lin CY, Thomsen JS, Fu PY, Murthy KR, Li H, Govindarajan KR, Nick LC, Bourque G, Gong Z, Lufkin T, Liu ET, Mathavan S. Molecular conservation of estrogen-response associated with cell cycle regulation, hormonal carcinogenesis and cancer in zebrafish and human cancer cell lines. Bmc Medical Genomics. 4: 41. PMID 21575170 DOI: 10.1186/1755-8794-4-41 |
0.385 |
|
| 2011 |
Hillmer AM, Yao F, Inaki K, Lee WH, Ariyaratne PN, Teo AS, Woo XY, Zhang Z, Zhao H, Ukil L, Chen JP, Zhu F, So JB, Salto-Tellez M, Poh WT, ... ... Liu ET, et al. Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes. Genome Research. 21: 665-75. PMID 21467267 DOI: 10.1101/Gr.113555.110 |
0.39 |
|
| 2011 |
Inaki K, Hillmer AM, Ukil L, Yao F, Woo XY, Vardy LA, Zawack KF, Lee CW, Ariyaratne PN, Chan YS, Desai KV, Bergh J, Hall P, Putti TC, Ong WL, ... ... Liu ET, et al. Transcriptional consequences of genomic structural aberrations in breast cancer. Genome Research. 21: 676-87. PMID 21467264 DOI: 10.1101/Gr.113225.110 |
0.365 |
|
| 2011 |
Li Y, Li Y, Wedrén S, Li G, Charn TH, Desai KV, Bonnard C, Czene K, Humphreys K, Darabi H, Einarsdóttir K, Heikkinen T, Aittomäki K, Blomqvist C, Chia KS, ... ... Liu ET, et al. Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer. Breast Cancer Research : Bcr. 13: R10. PMID 21269472 DOI: 10.1186/Bcr2817 |
0.335 |
|
| 2010 |
Kannan N, Kang J, Kong X, Tang J, Perry JK, Mohankumar KM, Miller LD, Liu ET, Mertani HC, Zhu T, Grandison PM, Liu DX, Lobie PE. Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma. Neoplasia (New York, N.Y.). 12: 1041-53. PMID 21170268 DOI: 10.1593/Neo.10916 |
0.334 |
|
| 2010 |
Low YL, Li Y, Humphreys K, Thalamuthu A, Li Y, Darabi H, Wedrén S, Bonnard C, Czene K, Iles MM, Heikkinen T, Aittomäki K, Blomqvist C, Nevanlinna H, Hall P, ... Liu ET, et al. Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility. Plos Genetics. 6: e1001012. PMID 20617168 DOI: 10.1371/Journal.Pgen.1001012 |
0.385 |
|
| 2010 |
Reekie K, Metspalu A, Chanock SJ, Liu ET, Mardis ER, Scherer SW, Kwok PY, Brookes AJ. HGV2009 meeting: bigger and better studies provide more answers and more questions. Human Mutation. 31: 886-8. PMID 20506253 DOI: 10.1002/Humu.21270 |
0.309 |
|
| 2010 |
Treiber T, Mandel EM, Pott S, Györy I, Firner S, Liu ET, Grosschedl R. Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin. Immunity. 32: 714-25. PMID 20451411 DOI: 10.1016/J.Immuni.2010.04.013 |
0.347 |
|
| 2010 |
Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabé RR, Bhan MK, Calvo F, Eerola I, Gerhard DS, Guttmacher A, Guyer M, Hemsley FM, Jennings JL, ... ... Liu ET, et al. International network of cancer genome projects. Nature. 464: 993-8. PMID 20393554 DOI: 10.1038/Nature08987 |
0.38 |
|
| 2010 |
Kang J, Qian PX, Pandey V, Perry JK, Miller LD, Liu ET, Zhu T, Liu DX, Lobie PE. Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma. Oncogene. 29: 3228-40. PMID 20305694 DOI: 10.1038/Onc.2010.71 |
0.336 |
|
| 2009 |
Liu ET. The Human Genome Organisation (HUGO). The Hugo Journal. 3: 3-4. PMID 21119760 DOI: 10.1007/S11568-010-9139-9 |
0.302 |
|
| 2009 |
Liu J, Desai KV, Li Y, Banu S, Lee YK, Qu D, Heikkinen T, Aaltonen K, Muranen TA, Kajiji TS, Bonnard C, Aittomäki K, von Smitten K, Blomqvist C, Hopper JL, ... ... Liu ET, et al. Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development. The Hugo Journal. 3: 31-40. PMID 21119756 DOI: 10.1007/S11568-010-9138-X |
0.407 |
|
| 2009 |
Kumar D, Liu ET. The emergence of 'The HUGO Journal'. The Hugo Journal. 3: 1-2. PMID 21119754 DOI: 10.1007/S11568-010-9140-3 |
0.313 |
|
| 2009 |
Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, Mohamed YB, Orlov YL, Velkov S, Ho A, Mei PH, Chew EG, Huang PY, Welboren WJ, Han Y, Ooi HS, ... ... Liu ET, et al. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature. 462: 58-64. PMID 19890323 DOI: 10.1038/Nature08497 |
0.319 |
|
| 2009 |
Fullwood MJ, Wei CL, Liu ET, Ruan Y. Next-generation DNA sequencing of paired-end tags (PET) for transcriptome and genome analyses. Genome Research. 19: 521-32. PMID 19339662 DOI: 10.1101/Gr.074906.107 |
0.306 |
|
| 2009 |
Einarsdóttir K, Darabi H, Czene K, Li Y, Low YL, Li YQ, Bonnard C, Wedrén S, Liu ET, Hall P, Liu J, Humphreys K. Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival. British Journal of Cancer. 100: 1358-64. PMID 19319135 DOI: 10.1038/Sj.Bjc.6604984 |
0.354 |
|
| 2009 |
Hamza MS, Pott S, Vega VB, Thomsen JS, Kandhadayar GS, Ng PW, Chiu KP, Pettersson S, Wei CL, Ruan Y, Liu ET. De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis. Plos One. 4: e4907. PMID 19300518 DOI: 10.1371/Journal.Pone.0004907 |
0.308 |
|
| 2008 |
Cheung AK, Lung HL, Hung SC, Law EW, Cheng Y, Yau WL, Bangarusamy DK, Miller LD, Liu ET, Shao JY, Kou CW, Chua D, Zabarovsky ER, Tsao SW, Stanbridge EJ, et al. Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma. Cancer Research. 68: 8137-45. PMID 18829573 DOI: 10.1158/0008-5472.Can-08-0904 |
0.386 |
|
| 2008 |
Liu ET. Functional genomics of cancer Current Opinion in Genetics and Development. 18: 251-256. PMID 18691651 DOI: 10.1016/J.Gde.2008.07.014 |
0.414 |
|
| 2008 |
Lam SH, Mathavan S, Tong Y, Li H, Karuturi RK, Wu Y, Vega VB, Liu ET, Gong Z. Zebrafish whole-adult-organism chemogenomics for large-scale predictive and discovery chemical biology. Plos Genetics. 4: e1000121. PMID 18618001 DOI: 10.1371/Journal.Pgen.1000121 |
0.306 |
|
| 2008 |
Jiang X, Tan J, Li J, Kivimäe S, Yang X, Zhuang L, Lee PL, Chan MT, Stanton LW, Liu ET, Cheyette BN, Yu Q. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell. 13: 529-41. PMID 18538736 DOI: 10.1016/J.Ccr.2008.04.019 |
0.309 |
|
| 2008 |
Ko JM, Chan PL, Yau WL, Chan HK, Chan KC, Yu ZY, Kwong FM, Miller LD, Liu ET, Yang LC, Lo PH, Stanbridge EJ, Tang JC, Srivastava G, Tsao SW, et al. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma. Molecular Cancer Research : McR. 6: 592-603. PMID 18403638 DOI: 10.1158/1541-7786.Mcr-07-0154 |
0.362 |
|
| 2008 |
Einarsdóttir K, Darabi H, Li Y, Low YL, Li YQ, Bonnard C, Sjölander A, Czene K, Wedrén S, Liu ET, Hall P, Humphreys K, Liu J. ESR1 and EGF genetic variation in relation to breast cancer risk and survival. Breast Cancer Research : Bcr. 10: R15. PMID 18271972 DOI: 10.1186/Bcr1861 |
0.353 |
|
| 2008 |
Denger S, Bähr-Ivacevic T, Brand H, Reid G, Blake J, Seifert M, Lin CY, May K, Benes V, Liu ET, Gannon F. Transcriptome profiling of estrogen-regulated genes in human primary osteoblasts reveals an osteoblast-specific regulation of the insulin-like growth factor binding protein 4 gene. Molecular Endocrinology (Baltimore, Md.). 22: 361-79. PMID 17962383 DOI: 10.1210/Me.2007-0292 |
0.381 |
|
| 2008 |
Leung AC, Wong VC, Yang LC, Chan PL, Daigo Y, Nakamura Y, Qi RZ, Miller LD, Liu ET, Wang LD, Li JL, Law S, Tsao SW, Lung ML. Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage-independent growth properties and impact on global gene expression in esophageal carcinoma. International Journal of Cancer. 122: 587-94. PMID 17943723 DOI: 10.1002/Ijc.23144 |
0.386 |
|
| 2007 |
Liu ET. Stromal effects in breast cancer New England Journal of Medicine. 357: 2537-2538. PMID 18094373 DOI: 10.1056/Nejmp0707576 |
0.355 |
|
| 2007 |
Petretto E, Liu ET, Aitman TJ. A gene harvest revealing the archeology and complexity of human disease. Nature Genetics. 39: 1299-301. PMID 17968342 DOI: 10.1038/Ng1107-1299 |
0.319 |
|
| 2007 |
Chiu KP, Ariyaratne P, Xu H, Tan A, Ng P, Liu ET, Ruan Y, Wei C, Sung WK. Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes. Bmc Cancer. 7: 109-109. PMID 17594473 DOI: 10.1186/1471-2407-7-109 |
0.346 |
|
| 2007 |
Lin CY, Vega VB, Thomsen JS, Zhang T, Kong SL, Xie M, Chiu KP, Lipovich L, Barnett DH, Stossi F, Yeo A, George J, Kuznetsov VA, Lee YK, Charn TH, ... ... Liu ET, et al. Whole-genome cartography of estrogen receptor alpha binding sites. Plos Genetics. 3: e87. PMID 17542648 DOI: 10.1371/Journal.Pgen.0030087 |
0.345 |
|
| 2007 |
Tan J, Yang X, Zhuang L, Jiang X, Chen W, Lee PL, Karuturi RK, Tan PB, Liu ET, Yu Q. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes & Development. 21: 1050-63. PMID 17437993 DOI: 10.1101/Gad.1524107 |
0.407 |
|
| 2007 |
Lin CY, Ström A, Li Kong S, Kietz S, Thomsen JS, Tee JB, Vega VB, Miller LD, Smeds J, Bergh J, Gustafsson JA, Liu ET. Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer. Breast Cancer Research : Bcr. 9: R25. PMID 17428314 DOI: 10.1186/Bcr1667 |
0.397 |
|
| 2007 |
Miller LD, Liu ET. Expression genomics in breast cancer research: Microarrays at the crossroads of biology and medicine Breast Cancer Research. 9. PMID 17397520 DOI: 10.1186/Bcr1662 |
0.425 |
|
| 2007 |
Liu ET, Lemberger T. Higher order structure in the cancer transcriptome and systems medicine. Molecular Systems Biology. 3: 94. PMID 17353936 DOI: 10.1038/Msb4100132 |
0.335 |
|
| 2007 |
Mohankumar KM, Xu XQ, Zhu T, Kannan N, Miller LD, Liu ET, Gluckman PD, Sukumar S, Emerald BS, Lobie PE. HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells. Oncogene. 26: 3998-4008. PMID 17213808 DOI: 10.1038/Sj.Onc.1210180 |
0.345 |
|
| 2007 |
Einarsdóttir K, Humphreys K, Bonnard C, Li Y, Li Y, Chia KS, Liu ET, Hall P, Liu J, Wedrén S. Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk. Human Molecular Genetics. 16: 154-64. PMID 17164260 DOI: 10.1093/Hmg/Ddl451 |
0.347 |
|
| 2007 |
Nilsson M, Stulnig TM, Lin CY, Yeo AL, Nowotny P, Liu ET, Steffensen KR. Liver X receptors regulate adrenal steroidogenesis and hypothalamic-pituitary-adrenal feedback. Molecular Endocrinology (Baltimore, Md.). 21: 126-37. PMID 16973760 DOI: 10.1210/Me.2006-0187 |
0.308 |
|
| 2006 |
Einarsdóttir K, Rosenberg LU, Humphreys K, Bonnard C, Palmgren J, Li Y, Li Y, Chia KS, Liu ET, Hall P, Liu J, Wedrén S. Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study. Breast Cancer Research : Bcr. 8: R67. PMID 17132159 DOI: 10.1186/Bcr1623 |
0.391 |
|
| 2006 |
Järvinen TA, Liu ET. Simultaneous amplification of HER-2 (ERBB2) and topoisomerase IIalpha (TOP2A) genes--molecular basis for combination chemotherapy in cancer. Current Cancer Drug Targets. 6: 579-602. PMID 17100565 DOI: 10.2174/156800906778742497 |
0.404 |
|
| 2006 |
Ivshina AV, George J, Senko O, Mow B, Putti TC, Smeds J, Lindahl T, Pawitan Y, Hall P, Nordgren H, Wong JE, Liu ET, Bergh J, Kuznetsov VA, Miller LD. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Research. 66: 10292-301. PMID 17079448 DOI: 10.1158/0008-5472.Can-05-4414 |
0.344 |
|
| 2006 |
Frasor J, Chang EC, Komm B, Lin CY, Vega VB, Liu ET, Miller LD, Smeds J, Bergh J, Katzenellenbogen BS. Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Research. 66: 7334-40. PMID 16849584 DOI: 10.1158/0008-5472.Can-05-4269 |
0.417 |
|
| 2006 |
Calza S, Hall P, Auer G, Bjöhle J, Klaar S, Kronenwett U, Liu ET, Miller L, Ploner A, Smeds J, Bergh J, Pawitan Y. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Research : Bcr. 8: R34. PMID 16846532 DOI: 10.1186/Bcr1517 |
0.346 |
|
| 2006 |
Hall P, Ploner A, Bjöhle J, Huang F, Lin CY, Liu ET, Miller LD, Nordgren H, Pawitan Y, Shaw P, Skoog L, Smeds J, Wedrén S, Ohd J, Bergh J. Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study. Bmc Medicine. 4: 16. PMID 16813654 DOI: 10.1186/1741-7015-4-16 |
0.376 |
|
| 2006 |
Einarsdóttir K, Humphreys K, Bonnard C, Palmgren J, Iles MM, Sjölander A, Li Y, Chia KS, Liu ET, Hall P, Liu J, Wedrén S. Linkage disequilibrium mapping of CHEK2: common variation and breast cancer risk. Plos Medicine. 3: e168. PMID 16671833 DOI: 10.1371/Journal.Pmed.0030168 |
0.392 |
|
| 2006 |
Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, Ponjavic J, Semple CA, Taylor MS, Engström PG, Frith MC, Forrest AR, Alkema WB, Tan SL, Plessy C, Kodzius R, ... ... Liu ET, et al. Genome-wide analysis of mammalian promoter architecture and evolution. Nature Genetics. 38: 626-35. PMID 16645617 DOI: 10.1038/Ng1789 |
0.346 |
|
| 2006 |
Liu ET, Kuznetsov VA, Miller LD. In the pursuit of complexity: systems medicine in cancer biology. Cancer Cell. 9: 245-7. PMID 16616330 DOI: 10.1016/J.Ccr.2006.03.026 |
0.422 |
|
| 2006 |
Broët P, Kuznetsov VA, Bergh J, Liu ET, Miller LD. Identifying gene expression changes in breast cancer that distinguish early and late relapse among uncured patients. Bioinformatics (Oxford, England). 22: 1477-85. PMID 16551658 DOI: 10.1093/Bioinformatics/Btl110 |
0.391 |
|
| 2006 |
Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu Y, Weng Z, Liu J, Zhao XD, Chew JL, Lee YL, Kuznetsov VA, ... ... Liu ET, et al. A global map of p53 transcription-factor binding sites in the human genome. Cell. 124: 207-19. PMID 16413492 DOI: 10.1016/J.Cell.2005.10.043 |
0.331 |
|
| 2006 |
Lipovich L, Vanisri RR, Kong SL, Lin CY, Liu ET. Primate-specific endogenous cis-antisense transcription in the human 5q31 protocadherin gene cluster. Journal of Molecular Evolution. 62: 73-88. PMID 16341467 DOI: 10.1007/S00239-005-0041-3 |
0.334 |
|
| 2006 |
Lam SH, Wu YL, Vega VB, Miller LD, Spitsbergen J, Tong Y, Zhan H, Govindarajan KR, Lee S, Mathavan S, Murthy KR, Buhler DR, Liu ET, Gong Z. Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nature Biotechnology. 24: 73-5. PMID 16327811 DOI: 10.1038/Nbt1169 |
0.339 |
|
| 2005 |
Pawitan Y, Bjöhle J, Amler L, Borg AL, Egyhazi S, Hall P, Han X, Holmberg L, Huang F, Klaar S, Liu ET, Miller L, Nordgren H, Ploner A, Sandelin K, et al. Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Research : Bcr. 7: R953-64. PMID 16280042 DOI: 10.1186/Bcr1325 |
0.355 |
|
| 2005 |
Zhao Y, Tan J, Zhuang L, Jiang X, Liu ET, Yu Q. Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim. Proceedings of the National Academy of Sciences of the United States of America. 102: 16090-5. PMID 16243973 DOI: 10.1073/Pnas.0505585102 |
0.36 |
|
| 2005 |
Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, Pawitan Y, Hall P, Klaar S, Liu ET, Bergh J. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival Proceedings of the National Academy of Sciences of the United States of America. 102: 13550-13555. PMID 16141321 DOI: 10.1073/Pnas.0506230102 |
0.363 |
|
| 2005 |
Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, Kodzius R, Shimokawa K, Bajic VB, Brenner SE, Batalov S, ... ... Liu ET, et al. The transcriptional landscape of the mammalian genome. Science (New York, N.Y.). 309: 1559-63. PMID 16141072 DOI: 10.1126/Science.1112014 |
0.317 |
|
| 2005 |
Mathavan S, Lee SG, Mak A, Miller LD, Murthy KR, Govindarajan KR, Tong Y, Wu YL, Lam SH, Yang H, Ruan Y, Korzh V, Gong Z, Liu ET, Lufkin T. Transcriptome analysis of zebrafish embryogenesis using microarrays. Plos Genetics. 1: 260-76. PMID 16132083 DOI: 10.1371/Journal.Pgen.0010029 |
0.354 |
|
| 2005 |
Lung HL, Bangarusamy DK, Xie D, Cheung AK, Cheng Y, Kumaran MK, Miller L, Liu ET, Guan XY, Sham JS, Fang Y, Li L, Wang N, Protopopov AI, Zabarovsky ER, et al. THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma. Oncogene. 24: 6525-32. PMID 16007174 DOI: 10.1038/Sj.Onc.1208812 |
0.347 |
|
| 2005 |
Dressler LG, Berry DA, Broadwater G, Cowan D, Cox K, Griffin S, Miller A, Tse J, Novotny D, Persons DL, Barcos M, Henderson IC, Liu ET, Thor A, Budman D, et al. Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 4287-97. PMID 15994142 DOI: 10.1200/Jco.2005.11.012 |
0.35 |
|
| 2005 |
Reid G, Métivier R, Lin CY, Denger S, Ibberson D, Ivacevic T, Brand H, Benes V, Liu ET, Gannon F. Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor alpha, in response to deacetylase inhibition by valproic acid and trichostatin A. Oncogene. 24: 4894-907. PMID 15870696 DOI: 10.1038/Sj.Onc.1208662 |
0.366 |
|
| 2005 |
Xu XQ, Emerald BS, Goh EL, Kannan N, Miller LD, Gluckman PD, Liu ET, Lobie PE. Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma. The Journal of Biological Chemistry. 280: 23987-4003. PMID 15845533 DOI: 10.1074/Jbc.M503869200 |
0.367 |
|
| 2005 |
Bimbó A, Jia Y, Poh SL, Karuturi RK, den Elzen N, Peng X, Zheng L, O'Connell M, Liu ET, Balasubramanian MK, Liu J. Systematic deletion analysis of fission yeast protein kinases. Eukaryotic Cell. 4: 799-813. PMID 15821139 DOI: 10.1128/Ec.4.4.799-813.2005 |
0.309 |
|
| 2005 |
Liu ET. Expression genomics and drug development: Towards predictive pharmacology Briefings in Functional Genomics and Proteomics. 3: 303-321. PMID 15814022 DOI: 10.1093/Bfgp/3.4.303 |
0.317 |
|
| 2005 |
Ng P, Wei CL, Sung WK, Chiu KP, Lipovich L, Ang CC, Gupta S, Shahab A, Ridwan A, Wong CH, Liu ET, Ruan Y. Gene identification signature (GIS) analysis for transcriptome characterization and genome annotation. Nature Methods. 2: 105-11. PMID 15782207 DOI: 10.1038/Nmeth733 |
0.365 |
|
| 2005 |
Liu ET. Mechanism-derived gene expression signatures and predictive biomarkers in clinical oncology Proceedings of the National Academy of Sciences of the United States of America. 102: 3531-3532. PMID 15738396 DOI: 10.1073/Pnas.0500244102 |
0.401 |
|
| 2005 |
Kang HJ, Nam SW, Kim H, Rhee H, Kim NG, Kim H, Hyung WJ, Noh SH, Kim JH, Yun CO, Liu ET, Kim H. Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors. Oncogene. 24: 1066-74. PMID 15690055 DOI: 10.1038/Sj.Onc.1208358 |
0.334 |
|
| 2005 |
Wei CL, Miura T, Robson P, Lim SK, Xu XQ, Lee MY, Gupta S, Stanton L, Luo Y, Schmitt J, Thies S, Wang W, Khrebtukova I, Zhou D, Liu ET, et al. Transcriptome profiling of human and murine ESCs identifies divergent paths required to maintain the stem cell state. Stem Cells (Dayton, Ohio). 23: 166-85. PMID 15671141 DOI: 10.1634/Stemcells.2004-0162 |
0.361 |
|
| 2005 |
Peng X, Karuturi RK, Miller LD, Lin K, Jia Y, Kondu P, Wang L, Wong LS, Liu ET, Balasubramanian MK, Liu J. Identification of cell cycle-regulated genes in fission yeast. Molecular Biology of the Cell. 16: 1026-42. PMID 15616197 DOI: 10.1091/Mbc.E04-04-0299 |
0.327 |
|
| 2005 |
Liu ET. Genomic technologies and the interrogation of the transcriptome Mechanisms of Ageing and Development. 126: 153-159. PMID 15610774 DOI: 10.1016/J.Mad.2004.09.027 |
0.34 |
|
| 2005 |
Loi S, Piccart M, Haibe-Kains B, Desmedt C, Harris AL, Bergh J, Tutt A, Miller LD, Liu ET, Sotiriou C. Prediction of early distant relapses on tamoxifen in early-stage breast cancer (BC): A potential tool for adjuvant aromatase inhibitor (AI) tailoring Journal of Clinical Oncology. 23: 509-509. DOI: 10.1200/Jco.2005.23.16_Suppl.509 |
0.338 |
|
| 2004 |
Miller L, Liu ET. Expression profiling and breast cancer biology. Breast Disease. 19: 29-34. PMID 15687695 DOI: 10.3233/Bd-2004-19105 |
0.4 |
|
| 2004 |
Steffensen KR, Neo SY, Stulnig TM, Vega VB, Rahman SS, Schuster GU, Gustafsson J, Liu ET. Genome-wide expression profiling; a panel of mouse tissues discloses novel biological functions of liver X receptors in adrenals. Journal of Molecular Endocrinology. 33: 609-622. PMID 15591022 DOI: 10.1677/Jme.1.01508 |
0.338 |
|
| 2004 |
Liu ET. Expression genomics and cancer biology Pharmacogenomics. 5: 1117-1128. PMID 15584878 DOI: 10.1517/14622416.5.8.1117 |
0.306 |
|
| 2004 |
Lebowitz PF, Eng-Wong J, Swain SM, Berman A, Merino MJ, Chow CK, Venzon D, Zia F, Danforth D, Liu E, Zujewski J. A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 6764-9. PMID 15501952 DOI: 10.1158/1078-0432.Ccr-04-0976 |
0.314 |
|
| 2004 |
Jazaeri AA, Chandramouli GV, Aprelikova O, Nuber UA, Sotiriou C, Liu ET, Ropers HH, Yee CJ, Boyd J, Barrett JC. BRCA1-mediated repression of select X chromosome genes. Journal of Translational Medicine. 2: 32. PMID 15383145 DOI: 10.1186/1479-5876-2-32 |
0.397 |
|
| 2004 |
Lung HL, Cheng Y, Kumaran MK, Liu ET, Murakami Y, Chan CY, Yau WL, Ko JM, Stanbridge EJ, Lung ML. Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma. International Journal of Cancer. Journal International Du Cancer. 112: 628-35. PMID 15382043 DOI: 10.1002/Ijc.20454 |
0.317 |
|
| 2004 |
Lin CY, Ström A, Vega VB, Kong SL, Yeo AL, Thomsen JS, Chan WC, Doray B, Bangarusamy DK, Ramasamy A, Vergara LA, Tang S, Chong A, Bajic VB, Miller LD, ... ... Liu ET, et al. Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biology. 5: R66. PMID 15345050 DOI: 10.1186/Gb-2004-5-9-R66 |
0.399 |
|
| 2004 |
Qiu TH, Chandramouli GV, Hunter KW, Alkharouf NW, Green JE, Liu ET. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease. Cancer Research. 64: 5973-81. PMID 15342376 DOI: 10.1158/0008-5472.Can-04-0242 |
0.378 |
|
| 2004 |
Wang Z, Li Y, Liu ET, Yu Q. Susceptibility to cell death induced by blockade of MAPK pathway in human colorectal cancer cells carrying Ras mutations is dependent on p53 status. Biochemical and Biophysical Research Communications. 322: 609-13. PMID 15325273 DOI: 10.1016/J.Bbrc.2004.07.166 |
0.344 |
|
| 2004 |
Wei CL, Ng P, Chiu KP, Wong CH, Ang CC, Lipovich L, Liu ET, Ruan Y. 5' Long serial analysis of gene expression (LongSAGE) and 3' LongSAGE for transcriptome characterization and genome annotation. Proceedings of the National Academy of Sciences of the United States of America. 101: 11701-11706. PMID 15272081 DOI: 10.1073/Pnas.0403514101 |
0.36 |
|
| 2004 |
Vega VB, Bangarusamy DK, Miller LD, Liu ET, Lin CY. BEARR: Batch Extraction and Analysis of cis-Regulatory Regions. Nucleic Acids Research. 32: W257-60. PMID 15215391 DOI: 10.1093/Nar/Gkh396 |
0.316 |
|
| 2004 |
Gilmore PM, McCabe N, Quinn JE, Kennedy RD, Gorski JJ, Andrews HN, McWilliams S, Carty M, Mullan PB, Duprex WP, Liu ET, Johnston PG, Harkin DP. BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3. Cancer Research. 64: 4148-54. PMID 15205325 DOI: 10.1158/0008-5472.Can-03-4080 |
0.323 |
|
| 2004 |
Welsh M, Welsh C, Ekman M, Dixelius J, Hägerkvist R, Annerén C, Akerblom B, Mahboobi S, Chandrasekharan S, Liu ET. The tyrosine kinase FRK/RAK participates in cytokine-induced islet cell cytotoxicity. The Biochemical Journal. 382: 261-8. PMID 15186217 DOI: 10.1042/Bj20040285 |
0.643 |
|
| 2004 |
Miller LD, McPhie P, Suzuki H, Kato Y, Liu ET, Cheng SY. Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance. Genome Biology. 5: R31. PMID 15128445 DOI: 10.1186/Gb-2004-5-5-R31 |
0.328 |
|
| 2004 |
Liu ET, Karuturi KR. Microarrays and clinical investigations. The New England Journal of Medicine. 350: 1595-1597. PMID 15084689 DOI: 10.1056/Nejmp048050 |
0.318 |
|
| 2004 |
Neo SY, Leow CK, Vega VB, Long PM, Islam AF, Lai PB, Liu ET, Ren EC. Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach. Hepatology (Baltimore, Md.). 39: 944-53. PMID 15057898 DOI: 10.1002/Hep.20105 |
0.332 |
|
| 2004 |
Wykoff CC, Sotiriou C, Cockman ME, Ratcliffe PJ, Maxwell P, Liu E, Harris AL. Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene. British Journal of Cancer. 90: 1235-43. PMID 15026807 DOI: 10.1038/Sj.Bjc.6601657 |
0.358 |
|
| 2004 |
Kho PS, Wang Z, Zhuang L, Li Y, Chew JL, Ng HH, Liu ET, Yu Q. p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis. The Journal of Biological Chemistry. 279: 21183-92. PMID 15016801 DOI: 10.1074/Jbc.M311912200 |
0.343 |
|
| 2004 |
Wong CW, Albert TJ, Vega VB, Norton JE, Cutler DJ, Richmond TA, Stanton LW, Liu ET, Miller LD. Tracking the evolution of the SARS coronavirus using high-throughput, high-density resequencing arrays. Genome Research. 14: 398-405. PMID 14993206 DOI: 10.1101/Gr.2141004 |
0.32 |
|
| 2004 |
Ruan Y, Ber PL, Ng HH, Liu ET. Interrogating the transcriptome Trends in Biotechnology. 22: 23-30. PMID 14690619 DOI: 10.1016/J.Tibtech.2003.11.002 |
0.354 |
|
| 2004 |
Liu ET. Expression genomics and cancer drug development Drug Development Research. 62: 295-302. DOI: 10.1002/Ddr.10388 |
0.4 |
|
| 2003 |
Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL, Liu ET. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proceedings of the National Academy of Sciences of the United States of America. 100: 10393-8. PMID 12917485 DOI: 10.1073/Pnas.1732912100 |
0.393 |
|
| 2003 |
Järvinen TAH, Liu ET. HER-2/neu and topoisomerase IIalpha--simultaneous drug targets in cancer. Combinatorial Chemistry & High Throughput Screening. 6: 455-470. PMID 12871052 DOI: 10.2174/138620703106298635 |
0.408 |
|
| 2003 |
Bajic VB, Tan SL, Chong A, Tang S, Ström A, Gustafsson JA, Lin CY, Liu ET. Dragon ERE Finder version 2: A tool for accurate detection and analysis of estrogen response elements in vertebrate genomes. Nucleic Acids Research. 31: 3605-7. PMID 12824376 DOI: 10.1093/Nar/Gkg517 |
0.316 |
|
| 2003 |
Järvinen TAH, Liu ET. Her-2/neu and Topoisomerase iiα in Breast Cancer Breast Cancer Research and Treatment. 78: 299-311. PMID 12755489 DOI: 10.1023/A:1023077507295 |
0.398 |
|
| 2003 |
Pusztai L, Sotiriou C, Buchholz TA, Meric F, Symmans WF, Esteva FJ, Sahin A, Liu ET, Hortobagi GN. Molecular profiles of invasive mucinous and ductal carcinomas of the breast: A molecular case study Cancer Genetics and Cytogenetics. 141: 148-153. PMID 12606133 DOI: 10.1016/S0165-4608(02)00737-9 |
0.406 |
|
| 2003 |
Liu ET. General keynote: expression profiling and the study of ovarian cancer Gynecologic Oncology. 88. PMID 12586078 DOI: 10.1006/Gyno.2002.6676 |
0.348 |
|
| 2003 |
Liu ET. Classification of cancers by expression profiling Current Opinion in Genetics and Development. 13: 97-103. PMID 12573442 DOI: 10.1016/S0959-437X(03)00008-X |
0.396 |
|
| 2003 |
Meyer T, Xu L, Chang J, Liu ET, Craven RJ, Cance WG. Breast cancer cell line proliferation blocked by the Src-related Rak tyrosine kinase. International Journal of Cancer. 104: 139-46. PMID 12569567 DOI: 10.1002/Ijc.10925 |
0.36 |
|
| 2003 |
Jazaeri AA, Lu K, Schmandt R, Harris CP, Rao PH, Sotiriou C, Chandramouli GVR, Gershenson DM, Liu ET. Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma Molecular Carcinogenesis. 36: 53-59. PMID 12557260 DOI: 10.1002/Mc.10098 |
0.378 |
|
| 2003 |
Liu E. Meta-analyses of transcriptional information: impact of data integration in understanding human breast cancers Breast Cancer Research. 5: 55-55. DOI: 10.1186/Bcr714 |
0.404 |
|
| 2002 |
Green JE, Cardiff R, Hennighausen L, Wakefield L, Wagner U, Lee E, Rosen J, Medina D, Nitkin A, Liu E. Validation of transgenic mammary cancer models: goals of the NCI Mouse Models of Human Cancer Consortium and the mammary cancer CD-ROM. Transgenic Research. 11: 635-6. PMID 12509138 DOI: 10.1023/A:1021140606271 |
0.331 |
|
| 2002 |
Miller LD, Long PM, Wong L, Mukherjee S, McShane LM, Liu ET. Optimal gene expression analysis by microarrays. Cancer Cell. 2: 353-61. PMID 12450790 DOI: 10.1016/S1535-6108(02)00181-2 |
0.345 |
|
| 2002 |
Malek RL, Irby RB, Guo QM, Lee K, Wong S, He M, Tsai J, Frank B, Liu ET, Quackenbush J, Jove R, Yeatman TJ, Lee NH. Identification of Src transformation fingerprint in human colon cancer. Oncogene. 21: 7256-65. PMID 12370817 DOI: 10.1038/Sj.Onc.1205900 |
0.406 |
|
| 2002 |
Liu ET, Sotiriou C. Defining the galaxy of gene expression in breast cancer Breast Cancer Research. 4: 141-144. PMID 12100738 DOI: 10.1186/Bcr438 |
0.403 |
|
| 2002 |
Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET. Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. Journal of the National Cancer Institute. 94: 990-1000. PMID 12096084 DOI: 10.1093/Jnci/94.13.990 |
0.395 |
|
| 2002 |
Chandrasekharan S, Qiu TH, Alkharouf N, Brantley K, Mitchell JB, Liu ET. Characterization of mice deficient in the Src family nonreceptor tyrosine kinase Frk/rak. Molecular and Cellular Biology. 22: 5235-47. PMID 12077350 DOI: 10.1128/Mcb.22.14.5235-5247.2002 |
0.673 |
|
| 2002 |
Sotiriou C, Powles TJ, Dowsett M, Jazaeri AA, Feldman AL, Assersohn L, Gadisetti C, Libutti SK, Liu ET. Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer Breast Cancer Research : Bcr. 4: R3. PMID 12052255 DOI: 10.1186/Bcr433 |
0.409 |
|
| 2002 |
Edgerton ME, Taylor R, Powell JI, Hunter L, Simon R, Liu ET. A bioinformatics tool to select sequences for microarray studies of mouse models of oncogenesis Bioinformatics. 18: 774-775. PMID 12050079 DOI: 10.1093/Bioinformatics/18.5.774 |
0.34 |
|
| 2002 |
Cozma D, Lukes L, Rouse J, Qiu TH, Liu ET, Hunter KW. A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers. Genome Research. 12: 969-75. PMID 12045150 DOI: 10.1101/Gr.210502 |
0.41 |
|
| 2002 |
Desai KV, Xiao N, Wang W, Gangi L, Greene J, Powell JI, Dickson R, Furth P, Hunter K, Kucherlapati R, Simon R, Liu ET, Green JE. Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proceedings of the National Academy of Sciences of the United States of America. 99: 6967-72. PMID 12011455 DOI: 10.1073/Pnas.102172399 |
0.425 |
|
| 2002 |
Sotiriou C, Khanna C, Jazaeri AA, Petersen D, Liu ET. Core biopsies can be used to distinguish differences in expression profiling by cDNA microarrays. The Journal of Molecular Diagnostics : Jmd. 4: 30-6. PMID 11826185 DOI: 10.1016/S1525-1578(10)60677-0 |
0.306 |
|
| 2002 |
Yu Q, He M, Lee NH, Liu ET. Identification of Myc-mediated death response pathways by microarray analysis. The Journal of Biological Chemistry. 277: 13059-66. PMID 11821411 DOI: 10.1074/Jbc.M111403200 |
0.326 |
|
| 2002 |
Bishop PC, Myers T, Robey R, Fry DW, Liu ET, Blagosklonny MV, Bates SE. Differential sensitivity of cancer cells to inhibitors of the epidermal growth factor receptor family. Oncogene. 21: 119-127. PMID 11791182 DOI: 10.1038/Sj.Onc.1205028 |
0.331 |
|
| 2001 |
Mullan PB, Quinn JE, Gilmore PM, McWilliams S, Andrews H, Gervin C, McCabe N, McKenna S, White P, Song YH, Maheswaran S, Liu E, Haber DA, Johnston PG, Harkin DP. BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents. Oncogene. 20: 6123-31. PMID 11593420 DOI: 10.1038/Sj.Onc.1204712 |
0.351 |
|
| 2001 |
Lee YT, Miller LD, Gubin AN, Makhlouf F, Wojda U, Barrett AJ, Liu ET, Miller JL. Transcription patterning of uncoupled proliferation and differentiation in myelodysplastic bone marrow with erythroid-focused arrays. Blood. 98: 1914-21. PMID 11535529 DOI: 10.1182/Blood.V98.6.1914 |
0.323 |
|
| 2001 |
Miller LD, Park KS, Guo QM, Alkharouf NW, Malek RL, Lee NH, Liu ET, Cheng SY. Silencing of Wnt signaling and activation of multiple metabolic pathways in response to thyroid hormone-stimulated cell proliferation. Molecular and Cellular Biology. 21: 6626-39. PMID 11533250 DOI: 10.1128/Mcb.21.19.6626-6639.2001 |
0.336 |
|
| 2001 |
Aprelikova O, Pace AJ, Fang B, Koller BH, Liu ET. BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. The Journal of Biological Chemistry. 276: 25647-50. PMID 11384963 DOI: 10.1074/Jbc.C100265200 |
0.402 |
|
| 2001 |
Campbell M, Aprelikova ON, van der Meer R, Woltjer RL, Yee CJ, Liu ET, Jensen RA. Construction and characterization of recombinant adenoviruses expressing human BRCA1 or murine Brca1 genes. Cancer Gene Therapy. 8: 231-9. PMID 11332994 DOI: 10.1038/Sj.Cgt.7700291 |
0.369 |
|
| 2001 |
Sotiriou C, Chand K, Petersen D, Jazaeri AA, Liu ET. Core biopsy versus surgical tumor specimens for microarray analysis of gene expression profiles Nature Genetics. 27: 88-89. DOI: 10.1038/87312 |
0.336 |
|
| 2001 |
Jazaeri A, Lu K, Sotiriou C, Alkharouf N, Gershenson D, Liu E. Gene expression profiles of low- and high-grade papillary serous ovarian carcinomas using cDNA microarray analysis Nature Genetics. 27: 62-62. DOI: 10.1038/87136 |
0.319 |
|
| 2001 |
Gangi L, Owens G, Rayford W, Liu E, Munroe D. Gene expression in prostate cancer: microarray analysis of tumor specimens from African American and Caucasian patients Nature Genetics. 27: 55-55. DOI: 10.1038/87086 |
0.346 |
|
| 2001 |
Dong G, Loukinova E, Chen Z, Gangi L, Liu E, Waes CV. Molecular profiling of metastatic tumor progression of a murine squamous cell carcinoma by differential display and cDNA microarray reveals dysregulated expression of genes related to the nuclear factor-κb signal pathway Nature Genetics. 27: 47-47. DOI: 10.1038/87034 |
0.352 |
|
| 2001 |
Aprelikova O, Pace A, Koller B, Liu E. Differential gene expression in cells with targeted deletion of BRCA1 tumor suppressor Nature Genetics. 27: 39-39. DOI: 10.1038/86982 |
0.367 |
|
| 2000 |
Paik S, Liu ET. HER2 as a Predictor of Therapeutic Response in Breast Cancer Breast Disease. 11: 91-102. PMID 15687595 DOI: 10.3233/Bd-1999-11108 |
0.369 |
|
| 2000 |
Järvinen TAH, Liu ET. Effects of HER-2/neu on chemosensitivity of tumor cells. Drug Resistance Updates. 3: 319-324. PMID 11498399 DOI: 10.1054/Drup.2000.0166 |
0.417 |
|
| 2000 |
Gardner K, Liu ET. BRCA1 function in T lymphocytes: a cellular specificity of a different kind Breast Cancer Research. 3: 11-13. PMID 11250741 DOI: 10.1186/Bcr263 |
0.355 |
|
| 1999 |
Lee WP, Liao Y, Robinson D, Kung HJ, Liu ET, Hung MC. Axl-gas6 interaction counteracts E1A-mediated cell growth suppression and proapoptotic activity. Molecular and Cellular Biology. 19: 8075-82. PMID 10567533 DOI: 10.1128/Mcb.19.12.8075 |
0.332 |
|
| 1999 |
Aprelikova ON, Fang BS, Meissner EG, Cotter S, Campbell M, Kuthiala A, Bessho M, Jensen RA, Liu ET. BRCA1-associated growth arrest is RB-dependent. Proceedings of the National Academy of Sciences of the United States of America. 96: 11866-71. PMID 10518542 DOI: 10.1073/Pnas.96.21.11866 |
0.346 |
|
| 1999 |
Li Y, Millikan RC, Newman B, Conway K, Tse CKJ, Liu ET. P57 (KIP2) polymorphisms and breast cancer risk. Human Genetics. 104: 83-88. PMID 10071197 DOI: 10.1007/S004390050914 |
0.342 |
|
| 1999 |
Johnston PG, Daly PA, Liu E. The NCI All Ireland Cancer Conference Oncologist. 4: 275-278. DOI: 10.1634/Theoncologist.4-4-275 |
0.317 |
|
| 1999 |
Gangi L, Owens G, Humphreys R, Hennighausen L, Liu E. Mammary gland involution studies with cDNA microarrays Nature Genetics. 23: 46-46. DOI: 10.1038/14308 |
0.361 |
|
| 1998 |
Liu E, Nealon E, Klausner R. Perspective from the National Cancer Institute (NCI). Breast Disease. 10: 29-31. PMID 15687583 DOI: 10.3233/Bd-1998-105-605 |
0.306 |
|
| 1998 |
Newman B, Liu ET. Perspective on BRCA1. Breast Disease. 10: 3-10. PMID 15687544 DOI: 10.3233/Bd-1998-101-203 |
0.367 |
|
| 1998 |
Guo Q, Xie J, Dang CV, Liu ET, Bishop JM. Identification of a large Myc-binding protein that contains RCC1-like repeats. Proceedings of the National Academy of Sciences of the United States of America. 95: 9172-7. PMID 9689053 DOI: 10.1073/Pnas.95.16.9172 |
0.332 |
|
| 1998 |
Liu ET. The uncoupling of race and cancer genetics Cancer. 83: 1765-1769. DOI: 10.1002/(Sici)1097-0142(19981015)83:8+<1765::Aid-Cncr19>3.0.Co;2-4 |
0.347 |
|
| 1995 |
Liu E, Nuzum C. Molecular sleuthing: Tracking ovarian cancer progression Journal of the National Cancer Institute. 87: 1099-1101. PMID 7674308 DOI: 10.1093/Jnci/87.15.1099 |
0.345 |
|
| 1993 |
Liu ET. From the molecule to public health New England Journal of Medicine. 329: 2028-2029. PMID 8247079 DOI: 10.1056/Nejm199312303292709 |
0.308 |
|
| Show low-probability matches. |